Tomoyuki Katsuno

902 total citations
40 papers, 554 citations indexed

About

Tomoyuki Katsuno is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Tomoyuki Katsuno has authored 40 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Molecular Biology and 10 papers in Surgery. Recurrent topics in Tomoyuki Katsuno's work include Diabetes Management and Research (22 papers), Diabetes Treatment and Management (21 papers) and Metabolism, Diabetes, and Cancer (12 papers). Tomoyuki Katsuno is often cited by papers focused on Diabetes Management and Research (22 papers), Diabetes Treatment and Management (21 papers) and Metabolism, Diabetes, and Cancer (12 papers). Tomoyuki Katsuno collaborates with scholars based in Japan, Australia and France. Tomoyuki Katsuno's co-authors include Mitsuyoshi Namba, Jun‐ichiro Miyagawa, Yoshiki Kusunoki, Masayuki Miuchi, Toshihiro Matsuo, Tomoya Hamaguchi, Fumihiro Ochi, Hidenori Koyama, Takafumi Akagami and Hiroki Ikeda and has published in prestigious journals such as SHILAP Revista de lepidopterología, Metabolism and Diabetic Medicine.

In The Last Decade

Tomoyuki Katsuno

39 papers receiving 538 citations

Peers

Countries citing papers authored by Tomoyuki Katsuno

Since Specialization

Citations

This map shows the geographic impact of Tomoyuki Katsuno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoyuki Katsuno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoyuki Katsuno more than expected).

Fields of papers citing papers by Tomoyuki Katsuno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoyuki Katsuno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoyuki Katsuno. The network helps show where Tomoyuki Katsuno may publish in the future.

Co-authorship network of co-authors of Tomoyuki Katsuno

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoyuki Katsuno. A scholar is included among the top collaborators of Tomoyuki Katsuno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoyuki Katsuno. Tomoyuki Katsuno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association between brain imaging biomarkers and continuous glucose monitoring-derived glycemic control indices in Japanese patients with type 2 diabetes mellitus 2024 ·BMJ Open Diabetes Research & Care ·Chikako Inoue, Yoshiki Kusunoki, (unknown), (unknown), Kazuhiro Kitajima, (unknown), Maki Inoue, (unknown), (unknown), (unknown), M Kadoya, (unknown), Tomoyuki Katsuno, Hidenori Koyama	4
2	Relationship Between Physical Activity and Estimated Glomerular Filtration Rate in Renal Transplant Recipients: A Cross-sectional Study Analyzing Isotemporal Substitution Model 2023 ·Journal of Renal Nutrition ·(unknown), Hidefumi Kishikawa, Akira Tamaki, Ryota Matsuzawa, Tomoyuki Katsuno, Toshiaki Miyamoto	0
3	Effect of Bain Unit Size on Low-temperature Fracture Toughness in Medium-carbon Martensitic and Bainitic Steels 2023 ·ISIJ International ·Akinobu Shibata, Tomoyuki Katsuno, (unknown), Nobuhiro Tsuji	7
4	Association between continuous glucose monitoring-derived glycemic control indices and urinary biomarkers of diabetic kidney disease: Hyogo Diabetes Hypoglycemia Cognition Complications study 2023 ·Acta Diabetologica ·(unknown), Yoshiki Kusunoki, (unknown), (unknown), Chikako Inoue, Maki Inoue, (unknown), M Kadoya, (unknown), Tomoyuki Katsuno, Hidenori Koyama, (unknown)	2
5	Association between low‐carbohydrate diets and continuous glucose monitoring‐derived time in ranges 2023 ·Journal of Diabetes Investigation ·(unknown), Yoshiki Kusunoki, (unknown), (unknown), Chikako Inoue, Maki Inoue, (unknown), (unknown), M Kadoya, (unknown), Tomoyuki Katsuno, Hidenori Koyama, (unknown)	2
6	Benefit of Early Add-on of Linagliptin to Insulin in Japanese Patients With Type 2 Diabetes Mellitus: Randomized-Controlled Open-Label Trial (TRUST2) 2021 ·Advances in Therapy ·(unknown), Tomoyuki Katsuno, Toshihiko Shiraiwa, (unknown), Hyohun Park, Nobuaki Watanabe, Shizuka Kaneko, Jungo Terasaki, Toshiaki Hanafusa, Akihisa Imagawa, Iichiro Shimomura, Hiroshi Ikegami, Hidenori Koyama, Mitsuyoshi Namba, Jun‐ichiro Miyagawa	3
7	Xanthine oxidoreductase activity is correlated with insulin resistance and subclinical inflammation in young humans 2017 ·Metabolism ·(unknown), Yoshiki Kusunoki, Takayo Murase, Takashi Nakamura, (unknown), (unknown), (unknown), Fumihiro Ochi, Toshihiro Matsuo, Tomoyuki Katsuno, Yuji Moriwaki, Tetsuya Yamamoto, Mitsuyoshi Namba, Hidenori Koyama	53
8	Medium-Term Effect of Add-On Therapy with the DPP-4 Inhibitor, Sitagliptin, in Insulin-Treated Japanese Patients with Type 2 Diabetes Mellitus 2016 ·Diabetes Therapy ·Tomoyuki Katsuno, Hiroki Ikeda, Mitsuyoshi Namba	2
9	Very Short-Term Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin on the Secretion of Insulin, Glucagon, and Incretin Hormones in Japanese Patients with Type 2 Diabetes Mellitus: Analysis of Meal Tolerance Test Data 2014 ·Drugs in R&D ·(unknown), Tomoyuki Katsuno, Jun‐ichiro Miyagawa, Toshihiro Matsuo, Fumihiro Ochi, (unknown), Yoshiki Kusunoki, Masayuki Miuchi, Mitsuyoshi Namba	14
10	Medium-Term Effects of Insulin Degludec on Patients with Type 1 Diabetes Mellitus 2014 ·Drugs in R&D ·(unknown), Yoshiki Kusunoki, Tomoyuki Katsuno, (unknown), Takafumi Akagami, (unknown), Tomoya Hamaguchi, Jun‐ichiro Miyagawa, Mitsuyoshi Namba	7
11	Effects of combination therapy with mitiglinide and voglibose on postprandial plasma glucose in patients with type 2 diabetes mellitus 2013 ·SHILAP Revista de lepidopterología ·Hiroyuki Konya, Tomoyuki Katsuno, (unknown), (unknown), (unknown), Masayuki Miuchi, Tomoya Hamaguchi, (unknown), Mitsuyoshi Namba	2
12	Effects of combination therapy with mitiglinide and voglibose on postprandial plasma glucose in patients with type 2 diabetes mellitus 2013 ·Diabetes Metabolic Syndrome and Obesity ·Hiroyuki Konya, Tomoyuki Katsuno, (unknown), (unknown), (unknown), Masayuki Miuchi, Tomoya Hamaguchi, Jun‐ichiro Miyagawa, Mitsuyoshi Namba	13
13	Effects of the naturally‐occurring disaccharides, palatinose and sucrose, on incretin secretion in healthy non‐obese subjects 2013 ·Journal of Diabetes Investigation ·Aya Maeda, Jun‐ichiro Miyagawa, Masayuki Miuchi, (unknown), (unknown), Toshihiro Matsuo, (unknown), Yoshiki Kusunoki, (unknown), (unknown), Tomoyuki Katsuno, Tomoya Hamaguchi, Yutaka Harano, Mitsuyoshi Namba	38
14	New strategy for the treatment of type 2 diabetes mellitus with incretin-based therapy 2012 ·Clinical and Experimental Nephrology ·Mitsuyoshi Namba, Tomoyuki Katsuno, Yoshiki Kusunoki, Toshihiro Matsuo, Masayuki Miuchi, Jun‐ichiro Miyagawa	18
15	Estimation of HbA1c response to sitagliptin by change in glycated albumin level for 2 weeks 2011 ·Journal of Diabetes Investigation ·Tomoya Hamaguchi, Masafumi Koga, Jun Murai, Hiroshi Saito, Daisuke Tamada, Shogo Kurebayashi, Tomoyuki Katsuno, Jun-ichiro Miyagawa, Mitsuyoshi Namba	10
16	Incretin responses to oral glucose load in Japanese non-obese healthy subjects 2011 ·Diabetes Therapy ·(unknown), Tomoyuki Katsuno, Jun‐ichiro Miyagawa, (unknown), Masayuki Miuchi, Fumihiro Ochi, Yoshiki Kusunoki, (unknown), (unknown), Tomoya Hamaguchi, Mitsuyoshi Namba	6
17	Asymmetric dimetylarginine (ADMA) could affect on cardiovascular complications in type 2 diabetes, particularly complicated with nephropathy 2010 ·Endocrine Journal ·(unknown), Tomoyuki Katsuno, Tomoya Hamaguchi, J Miyagawa, Mitsuyoshi Namba, (unknown), (unknown), Yasuo Kusunoki, Hiroyuki Konya, Masayuki Miuchi, Takehiko Ueyama, (unknown), (unknown)	1
18	Effects of gliclazide on platelet aggregation and the plasminogen activator inhibitor type 1 level in patients with type 2 diabetes mellitus 2010 ·Metabolism ·Hiroyuki Konya, Yoshikazu Hasegawa, Tomoya Hamaguchi, (unknown), (unknown), Tomoyuki Katsuno, Tetsuya Ishikawa, Masayuki Miuchi, (unknown), Akira Suehiro, Eizo Kakishita, Jun‐ichiro Miyagawa, Mitsuyoshi Namba	17
19	Clinical significance of circulating hepatocyte growth factor, a new risk marker of carotid atherosclerosis in patients with Type 2 diabetes 2006 ·Diabetic Medicine ·(unknown), Hiroyuki Konya, Tomoya Hamaguchi, (unknown), Tomoyuki Katsuno, Tetsuya Ishikawa, (unknown), (unknown), Akira Suehiro, Eizo Kakishita, Mitsuyoshi Namba	27
20	CHANGES OF CYTOKINES DURING THE COURSE OF GRAFT-VERSUS-HOST DISEASE FOLLOWING BONE MARROW TRANSPLANTATION: A CASE REPORT 2000 ·Cytokine ·Hiroyuki Takatsuka, Y Takemoto, Masaya Okada, Akihiro Sawada, Tomoyuki Katsuno, Hiroshi Wada, Eizo Kakishita	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact